Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-23 Sale | 2023-10-25 4:28 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 6,000 | $5.0767 | $30,460 | 129,917 (Indirect Direct) | View |
| 2023-08-21 Sale | 2023-08-22 4:31 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 6,000 | $7.3158 | $43,895 | 135,917 (Indirect Direct) | View |
| 2023-06-20 Sale | 2023-06-22 4:30 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 6,000 | $10.28 | $61,663 | 141,917 (Indirect Direct) | View |
| 2023-03-02 Sale | 2023-03-03 8:12 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 30,837 | $12.51 | $385,639 | 293,192 (Indirect Direct) | View |
| 2023-02-15 Sale | 2023-02-17 4:34 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 5,000 | $13.06 | $65,310 | 91,579 (Indirect Direct) | View |
| 2022-12-15 Sale | 2022-12-16 4:57 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 5,000 | $15.88 | $79,412 | 96,579 (Indirect Direct) | View |
| 2022-10-17 Sale | 2022-10-19 4:45 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 5,000 | $15.98 | $79,908 | 101,579 (Indirect Direct) | View |
| 2022-04-18 Sale | 2022-04-20 5:06 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 30,000 | $16.28 | $488,298 | 106,579 (Indirect Direct) | View |
| 2022-03-10 Sale | 2022-03-14 4:53 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 27,165 | $15.71 | $426,803 | 136,579 (Indirect Direct) | View |
| 2022-02-09 Sale | 2022-02-11 4:22 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 383 | $12.68 | $4,857 | 87,494 (Indirect Direct) | View |
| 2021-06-02 Sale | 2021-06-02 9:45 pm | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 21,790 | $21.64 | $471,437 | 85,535 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Tax Withholding | 2024-03-05 5:04 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 21,283 | $1.24 | 258,826 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 5:04 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 73,425 | $0 | 258,826 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 7:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 2,583 | $1.2 | 570,334 (Direct) | View |
| 2024-02-01 Exercise | 2024-02-05 7:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 7,500 | $0 | 570,334 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:31 pm | N/A 2034-01-31 | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 413,000 | $0 | 570,334 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 8:12 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 87,175 | $0 | 293,192 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:07 pm | N/A 2033-01-31 | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:11 pm | N/A 2032-02-29 | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 196,800 | $0 | 549,294 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-03 6:11 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 76,250 | $0 | 549,294 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-03 4:49 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 1,050 | $0 | 87,877 (Direct) | View |
| 2021-09-01 Tax Withholding | 2021-09-02 5:39 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 1,041 | $17.22 | 86,827 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-02 5:39 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 2,333 | $0 | 86,827 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-02 9:45 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 50,000 | $0 | 85,535 (Direct) | View |
Ownership | 2021-05-17 6:06 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer | 0 | $0 | 446,408 (Direct) | View |